A citation-based method for searching scientific literature

William W Busse, Sally E Wenzel, Thomas B Casale, J Mark FitzGerald, Megan S Rice, Nadia Daizadeh, Yamo Deniz, Naimish Patel, Sivan Harel, Paul J Rowe, Neil M H Graham, Thomas O'Riordan, Ian D Pavord. Lancet Respir Med 2021
Times Cited: 16







List of co-cited articles
75 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.
Mario Castro, Jonathan Corren, Ian D Pavord, Jorge Maspero, Sally Wenzel, Klaus F Rabe, William W Busse, Linda Ford, Lawrence Sher, J Mark FitzGerald,[...]. N Engl J Med 2018
698
50

Prognostic and Predictive Value of Blood Eosinophil Count, Fractional Exhaled Nitric Oxide, and Their Combination in Severe Asthma: A Post Hoc Analysis.
Rahul Shrimanker, Oliver Keene, Gareth Hynes, Sally Wenzel, Steven Yancey, Ian D Pavord. Am J Respir Crit Care Med 2019
44
43

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
Ian D Pavord, Stephanie Korn, Peter Howarth, Eugene R Bleecker, Roland Buhl, Oliver N Keene, Hector Ortega, Pascal Chanez. Lancet 2012
31

Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide.
Simon Couillard, Annette Laugerud, Maisha Jabeen, Sanjay Ramakrishnan, James Melhorn, Timothy Hinks, Ian Pavord. Thorax 2022
11
45

Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial.
Ian D Pavord, Mark Holliday, Helen K Reddel, Irene Braithwaite, Stefan Ebmeier, Robert J Hancox, Tim Harrison, Claire Houghton, Karen Oldfield, Alberto Papi,[...]. Lancet Respir Med 2020
50
31

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.
Klaus F Rabe, Parameswaran Nair, Guy Brusselle, Jorge F Maspero, Mario Castro, Lawrence Sher, Hongjie Zhu, Jennifer D Hamilton, Brian N Swanson, Asif Khan,[...]. N Engl J Med 2018
456
25

Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline.
Fernando Holguin, Juan Carlos Cardet, Kian Fan Chung, Sarah Diver, Diogenes S Ferreira, Anne Fitzpatrick, Mina Gaga, Liz Kellermeyer, Sandhya Khurana, Shandra Knight,[...]. Eur Respir J 2020
179
25

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.
Kian Fan Chung, Sally E Wenzel, Jan L Brozek, Andrew Bush, Mario Castro, Peter J Sterk, Ian M Adcock, Eric D Bateman, Elisabeth H Bel, Eugene R Bleecker,[...]. Eur Respir J 2014
25

Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma.
Simon Couillard, Rahul Shrimanker, Rekha Chaudhuri, Adel H Mansur, Lorcan P McGarvey, Liam G Heaney, Stephen J Fowler, Peter Bradding, Ian D Pavord, Timothy S C Hinks. Am J Respir Crit Care Med 2021
14
28

Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma.
Monica Kraft, Guy Brusselle, J Mark FitzGerald, Ian D Pavord, Matthew Keith, Malin Fagerås, Esther Garcia Gil, Ian Hirsch, Mitchell Goldman, Gene Colice. Eur Respir J 2021
9
44

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
Laurie A Lee, Zelie Bailes, Neil Barnes, Louis-Philippe Boulet, Dawn Edwards, Andrew Fowler, Nicola A Hanania, Huib A M Kerstjens, Edward Kerwin, Robert Nathan,[...]. Lancet Respir Med 2021
54
25

Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.
D Robinson, M Humbert, R Buhl, A A Cruz, H Inoue, S Korom, N A Hanania, P Nair. Clin Exp Allergy 2017
184
18

Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
Liam G Heaney, John Busby, Catherine E Hanratty, Ratko Djukanovic, Ashley Woodcock, Samantha M Walker, Timothy C Hardman, Joseph R Arron, David F Choy, Peter Bradding,[...]. Lancet Respir Med 2021
41
18

After asthma: redefining airways diseases.
Ian D Pavord, Richard Beasley, Alvar Agusti, Gary P Anderson, Elisabeth Bel, Guy Brusselle, Paul Cullinan, Adnan Custovic, Francine M Ducharme, John V Fahy,[...]. Lancet 2018
476
18

Mepolizumab treatment in patients with severe eosinophilic asthma.
Hector G Ortega, Mark C Liu, Ian D Pavord, Guy G Brusselle, J Mark FitzGerald, Alfredo Chetta, Marc Humbert, Lynn E Katz, Oliver N Keene, Steven W Yancey,[...]. N Engl J Med 2014
18

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Ioana Agache, Jessica Beltran, Cezmi Akdis, Mubeccel Akdis, Carlos Canelo-Aybar, Giorgio Walter Canonica, Thomas Casale, Tomas Chivato, Jonathan Corren, Stefano Del Giacco,[...]. Allergy 2020
79
18

Standardisation of spirometry.
M R Miller, J Hankinson, V Brusasco, F Burgos, R Casaburi, A Coates, R Crapo, P Enright, C P M van der Grinten, P Gustafsson,[...]. Eur Respir J 2005
18

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.
David B Price, Anna Rigazio, Jonathan D Campbell, Eugene R Bleecker, Christopher J Corrigan, Mike Thomas, Sally E Wenzel, Andrew M Wilson, Mary Buatti Small, Gokul Gopalan,[...]. Lancet Respir Med 2015
291
18

Treatable traits: toward precision medicine of chronic airway diseases.
Alvar Agusti, Elisabeth Bel, Mike Thomas, Claus Vogelmeier, Guy Brusselle, Stephen Holgate, Marc Humbert, Paul Jones, Peter G Gibson, Jørgen Vestbo,[...]. Eur Respir J 2016
497
18

An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.
Raed A Dweik, Peter B Boggs, Serpil C Erzurum, Charles G Irvin, Margaret W Leigh, Jon O Lundberg, Anna-Carin Olin, Alan L Plummer, D Robin Taylor. Am J Respir Crit Care Med 2011
18

Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study.
Thomas B Casale, Allan T Luskin, William Busse, Robert S Zeiger, Benjamin Trzaskoma, Ming Yang, Noelle M Griffin, Bradley E Chipps. J Allergy Clin Immunol Pract 2019
88
18


Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.
Andrew Menzies-Gow, Jonathan Corren, Arnaud Bourdin, Geoffrey Chupp, Elliot Israel, Michael E Wechsler, Christopher E Brightling, Janet M Griffiths, Åsa Hellqvist, Karin Bowen,[...]. N Engl J Med 2021
85
18

Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.
Nicola A Hanania, Sally Wenzel, Karin Rosén, Hsin-Ju Hsieh, Sofia Mosesova, David F Choy, Preeti Lal, Joseph R Arron, Jeffrey M Harris, William Busse. Am J Respir Crit Care Med 2013
553
18

Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis.
Jorge F Maspero, Constance H Katelaris, William W Busse, Mario Castro, Jonathan Corren, Bradley E Chipps, Anju T Peters, Ian D Pavord, Linda B Ford, Lawrence Sher,[...]. J Allergy Clin Immunol Pract 2020
17
12

Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients.
Philip E Silkoff, Michel Laviolette, Dave Singh, J Mark FitzGerald, Steven Kelsen, Vibeke Backer, Celeste M Porsbjerg, Pierre-Olivier Girodet, Patrick Berger, Joel N Kline,[...]. J Allergy Clin Immunol 2017
41
12

NO or no NO in asthma?
P J Barnes. Thorax 1996
103
12



Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma.
William W Busse, Jorge F Maspero, Klaus F Rabe, Alberto Papi, Sally E Wenzel, Linda B Ford, Ian D Pavord, Bingzhi Zhang, Heribert Staudinger, Gianluca Pirozzi,[...]. Adv Ther 2018
65
12

Tezepelumab in Adults with Uncontrolled Asthma.
Jonathan Corren, Jane R Parnes, Liangwei Wang, May Mo, Stephanie L Roseti, Janet M Griffiths, René van der Merwe. N Engl J Med 2017
435
12

The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma.
Diarmuid M McNicholl, Michael Stevenson, Lorcan P McGarvey, Liam G Heaney. Am J Respir Crit Care Med 2012
111
12

Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma.
Liam G Heaney, John Busby, Peter Bradding, Rekha Chaudhuri, Adel H Mansur, Robert Niven, Ian D Pavord, John T Lindsay, Richard W Costello. Am J Respir Crit Care Med 2019
62
12

Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma.
Raed A Dweik, Ronald L Sorkness, Sally Wenzel, Jeffrey Hammel, Douglas Curran-Everett, Suzy A A Comhair, Eugene Bleecker, William Busse, William J Calhoun, Mario Castro,[...]. Am J Respir Crit Care Med 2010
203
12

The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
P Jane McDowell, Sarah Diver, Freda Yang, Catherine Borg, John Busby, Vanessa Brown, Rahul Shrimanker, Ciara Cox, Christopher E Brightling, Rekha Chaudhuri,[...]. Lancet Respir Med 2021
10
20

The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA.
Robert Y Suruki, Jonas B Daugherty, Nada Boudiaf, Frank C Albers. BMC Pulm Med 2017
112
12

A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma.
Dominick Shaw, Ruth Green, Mike Berry, Sarah Mellor, Beverley Hargadon, Maria Shelley, Sue McKenna, Mike Thomas, Ian Pavord. Prim Care Respir J 2012
28
12

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.
R M Conroy, K Pyörälä, A P Fitzgerald, S Sans, A Menotti, G De Backer, D De Bacquer, P Ducimetière, P Jousilahti, U Keil,[...]. Eur Heart J 2003
12

Cluster analysis and clinical asthma phenotypes.
Pranab Haldar, Ian D Pavord, Dominic E Shaw, Michael A Berry, Michael Thomas, Christopher E Brightling, Andrew J Wardlaw, Ruth H Green. Am J Respir Crit Care Med 2008
12

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
W Busse, J Corren, B Q Lanier, M McAlary, A Fowler-Taylor, G D Cioppa, A van As, N Gupta. J Allergy Clin Immunol 2001
853
12

Anti-IL5 therapies for asthma.
Hugo A Farne, Amanda Wilson, Colin Powell, Lynne Bax, Stephen J Milan. Cochrane Database Syst Rev 2017
214
12

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
Sally Wenzel, Mario Castro, Jonathan Corren, Jorge Maspero, Lin Wang, Bingzhi Zhang, Gianluca Pirozzi, E Rand Sutherland, Robert R Evans, Vijay N Joish,[...]. Lancet 2016
506
12

Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma.
S D Sullivan, L Rasouliyan, P A Russo, T Kamath, B E Chipps. Allergy 2007
136
12

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Ioana Agache, Claudio Rocha, Jessica Beltran, Yang Song, Margarita Posso, Ivan Solà, Pablo Alonso-Coello, Cezmi Akdis, Mubeccel Akdis, Giorgio W Canonica,[...]. Allergy 2020
40
12

Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.
Jonathan Corren, Mario Castro, Thomas O'Riordan, Nicola A Hanania, Ian D Pavord, Santiago Quirce, Bradley E Chipps, Sally E Wenzel, Karthinathan Thangavelu, Megan S Rice,[...]. J Allergy Clin Immunol Pract 2020
62
12

A European Respiratory Society technical standard: exhaled biomarkers in lung disease.
Ildiko Horváth, Peter J Barnes, Stelios Loukides, Peter J Sterk, Marieann Högman, Anna-Carin Olin, Anton Amann, Balazs Antus, Eugenio Baraldi, Andras Bikov,[...]. Eur Respir J 2017
273
12

Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.
Joanne E Kavanagh, Andrew P Hearn, Jaideep Dhariwal, Gráinne d'Ancona, Abdel Douiri, Cris Roxas, Mariana Fernandes, Linda Green, Louise Thomson, Alexandra M Nanzer,[...]. Chest 2021
61
12

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.
Geoffrey L Chupp, Eric S Bradford, Frank C Albers, Daniel J Bratton, Jie Wang-Jairaj, Linda M Nelsen, Jennifer L Trevor, Antoine Magnan, Anneke Ten Brinke. Lancet Respir Med 2017
282
12

Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic Asthma.
Joanne E Kavanagh, Grainne d'Ancona, Maria Elstad, Linda Green, Mariana Fernandes, Louise Thomson, Cris Roxas, Jaideep Dhariwal, Alexandra M Nanzer, Brian D Kent,[...]. Chest 2020
70
12



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.